229 related articles for article (PubMed ID: 87201)
21. The isoenzyme selectivity of AH 21-132 as an inhibitor of cyclic nucleotide phosphodiesterase activity.
Elliott KR; Berry JL; Bate AJ; Foster RW; Small RC
J Enzyme Inhib; 1991; 4(3):245-51. PubMed ID: 1645399
[TBL] [Abstract][Full Text] [Related]
22. Phosphodiesterase 4 inhibitors as airways smooth muscle relaxant agents: synthesis and biological activities of triazine derivatives.
Leroux F; van Keulen BJ; Daliers J; Pommery N; Hénichart JP
Bioorg Med Chem; 1999 Mar; 7(3):509-16. PubMed ID: 10220036
[TBL] [Abstract][Full Text] [Related]
23. Hypertrophied right hearts get two for the price of one: can inhibiting phosphodiesterase type 5 also inhibit phosphodiesterase type 3?
Kass DA
Circulation; 2007 Jul; 116(3):233-5. PubMed ID: 17638937
[No Abstract] [Full Text] [Related]
24. Characterization and selective inhibition of cyclic nucleotide phosphodiesterase isozymes in canine tracheal smooth muscle.
Torphy TJ; Cieslinski LB
Mol Pharmacol; 1990 Feb; 37(2):206-14. PubMed ID: 2154670
[TBL] [Abstract][Full Text] [Related]
25. Effect of 3-isobutyl-1-methylxanthine and zaprinast on non-adrenergic non-cholinergic relaxation in the rat gastric fundus.
Barbier AJ; Lefebvre RA
Eur J Pharmacol; 1992 Jan; 210(3):315-23. PubMed ID: 1377130
[TBL] [Abstract][Full Text] [Related]
26. Effects of visnagin on cyclic nucleotide phosphodiesterases and their role in its inhibitory effects on vascular smooth muscle contraction.
Duarte J; Lugnier C; Torres AI; Pérez-Vizcaino F; Zarzuelo A; Tamargo J
Gen Pharmacol; 1999 Jan; 32(1):71-4. PubMed ID: 9888257
[TBL] [Abstract][Full Text] [Related]
27. Modulation of carbachol-induced inositol phosphate formation in bovine tracheal smooth muscle by cyclic AMP phosphodiesterase inhibitors.
Hall IP; Donaldson J; Hill SJ
Biochem Pharmacol; 1990 Apr; 39(8):1357-63. PubMed ID: 1690998
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of cyclic nucleotide phosphodiesterases by methylxanthines and related compounds.
Francis SH; Sekhar KR; Ke H; Corbin JD
Handb Exp Pharmacol; 2011; (200):93-133. PubMed ID: 20859794
[TBL] [Abstract][Full Text] [Related]
29. Cyclic nucleotide phosphodiesterase activities of the embryonic chick ovary.
Teng CT; Buchler B; Teng CS
Gen Comp Endocrinol; 1981 Aug; 44(4):409-17. PubMed ID: 6167486
[No Abstract] [Full Text] [Related]
30. Selective inhibition of cyclic AMP and cyclic GMP phosphodiesterases of cardiac nuclear fraction.
Ahluwalia GS; Rhoads AR
Biochem Pharmacol; 1982 Mar; 31(5):665-9. PubMed ID: 6177320
[TBL] [Abstract][Full Text] [Related]
31. Substituted pyrazolopyridines as potent and selective PDE5 inhibitors: potential agents for treatment of erectile dysfunction.
Yu G; Mason HJ; Wu X; Wang J; Chong S; Dorough G; Henwood A; Pongrac R; Seliger L; He B; Normandin D; Adam L; Krupinski J; Macor JE
J Med Chem; 2001 Mar; 44(7):1025-7. PubMed ID: 11297448
[No Abstract] [Full Text] [Related]
32. Relaxant effects of various xanthine derivatives. Relationship to cyclic nucleotide phosphodiesterase inhibition.
Takagi K; Ogawa K; Tanaka H; Satake T; Watanabe Y; Chijiwa T; Hidaka H
Adv Second Messenger Phosphoprotein Res; 1992; 25():353-62. PubMed ID: 1313267
[No Abstract] [Full Text] [Related]
33. Inhibitors of cyclic nucleotide phosphodiesterase isoenzymes--their potential utility in the therapy of asthma.
Nicholson CD; Shahid M
Pulm Pharmacol; 1994 Feb; 7(1):1-17. PubMed ID: 8003849
[No Abstract] [Full Text] [Related]
34. Inhibition of human lung cyclic nucleotide phosphodiesterases by proxyphylline, theophylline and their metabolites.
Selvig K; Bjerve KS
Acta Pharmacol Toxicol (Copenh); 1982 Sep; 51(3):250-2. PubMed ID: 6291318
[TBL] [Abstract][Full Text] [Related]
35. Inhibitors of cyclic nucleotide phosphodiesterases as therapeutic agents.
Murray KJ; England PJ
Biochem Soc Trans; 1992 May; 20(2):460-4. PubMed ID: 1327922
[No Abstract] [Full Text] [Related]
36. Inhibition of cyclic GMP phosphodiesterase by xanthine derivatives relaxes guinea-pig trachealis smooth muscle.
Tanaka H; Ogawa K; Takagi K; Satake T; Hidaka H
Clin Exp Pharmacol Physiol; 1991 Mar; 18(3):163-8. PubMed ID: 1647281
[TBL] [Abstract][Full Text] [Related]
37. Measurements of cyclic AMP and cyclic GMP phosphodiesterase activity in isolated tubular segments.
Jackson BA; Edwards RM; Dousa TP
Kidney Int; 1980 Oct; 18(4):512-8. PubMed ID: 6164816
[No Abstract] [Full Text] [Related]
38. Mechanism of xanthine-induced relaxation of guinea-pig isolated trachealis muscle.
Ogawa K; Takagi K; Satake T
Br J Pharmacol; 1989 Jun; 97(2):542-6. PubMed ID: 2547475
[TBL] [Abstract][Full Text] [Related]
39. Novel compounds possessing potent cAMP and cGMP phosphodiesterase inhibitory activity. Synthesis and cardiovascular effects of a series of imidazo[1,2-a]quinoxalinones and imidazo[1,5-a]quinoxalinones and their aza analogues.
Davey DD; Erhardt PW; Cantor EH; Greenberg SS; Ingebretsen WR; Wiggins J
J Med Chem; 1991 Sep; 34(9):2671-7. PubMed ID: 1654425
[TBL] [Abstract][Full Text] [Related]
40. Do conventional plasma cyclic nucleotide phosphodiesterase inhibitors really work in all situations?
Wood PJ; Pao G; Ross G; Smith C
Clin Chim Acta; 1981 Sep; 115(3):405-8. PubMed ID: 6271425
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]